Journal of the Pediatric Infectious Diseases Society · 2022 · 27 citations · 6 references
MedicineInfectious DiseasesPediatricsAdolescent HealthAdolescent MedicineVirologyAntiviral TherapyImmunocompromised Host InfectionsInfectious Disease PreventionPediatric TransplantationTransplant Infectious ComplicationsViral InfectionsCytomegalovirus DiseaseCytomegalovirus TherapyInfection Prevention After TransplantationPediatric Viral InfectionsPost-transplant Cytomegalovirus InfectionTransplant-associated InfectionsTreatment Of Cytomegalovirus InfectionViral Infection Treatment
There are limited data for letermovir as primary cytomegalovirus (CMV) prophylaxis in patients less than 18 years of age. We report 9 adolescent patients who received letermovir following hematopoietic cell transplantation. No patients developed clinically significant CMV while taking letermovir. Letermovir was well tolerated and efficacious in preventing CMV infections.
6
P.S. Verghese, M.R. Schleiss · Drugs of the Future · 2013 · 42 citations · Full text
Thomas Bontant, Petr Sedláček, Adriana Balduzzi et al. · Bone Marrow Transplantation · 2013 · 31 citations